Cargando…

METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m(6)A Modification

We aimed to investigate the bio-functions of METTL3 in promoting breast cancer (BCa) progression via regulating N6-methyladenosine (m(6)A) modification of EZH2 mRNA. METTL3 levels in 48 cases of BCa and matched paracancerous tissues were detected. In the meantime, METTL3 in BCa patients with differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Shaojun, Song, Yang, Zhou, Yu, Jiao, Yu, Li, Guopeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983232/ https://www.ncbi.nlm.nih.gov/pubmed/35392146 http://dx.doi.org/10.1155/2022/5794422

Ejemplares similares

Retracted: METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m(6)A Modification
por: Healthcare Engineering, Journal of
Publicado: (2023)

METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
por: Zhou, Xinying, et al.
Publicado: (2022)

Corrigendum: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification
por: Zhou, Xinying, et al.
Publicado: (2023)

METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021)

Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification regulates cell cycle progression of dental pulp stem cells
por: Luo, Haiyun, et al.
Publicado: (2021)

METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
por: Cai, Jingli, et al.
Publicado: (2022)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression
por: Guo, Yu-qing, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification is required for cerebellar development
por: Wang, Chen-Xin, et al.
Publicado: (2018)

HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020)

METTL3-dependent m(6)A modification programs T follicular helper cell differentiation
por: Yao, Yingpeng, et al.
Publicado: (2021)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021)

METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021)

Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer
por: Sun, Lianhui, et al.
Publicado: (2023)

CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression
por: Li, Zhi, et al.
Publicado: (2021)

The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
por: Cheng, Yingying, et al.
Publicado: (2020)

METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
por: Wang, Xiaotong, et al.
Publicado: (2023)

Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1
por: Yang, Jue, et al.
Publicado: (2023)

Mechanistic insights into m(6)A modification of U6 snRNA by human METTL16
por: Aoyama, Tomohiko, et al.
Publicado: (2020)

Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3‐mediated N6‐methyladenosine modification of ICAM2 mRNA in fibroblast‐like synoviocytes
por: Chen, Jian, et al.
Publicado: (2022)

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m(6)A modification of TRPC3 mRNA
por: Shen, Zhangjin, et al.
Publicado: (2022)

METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification
por: Zhang, Xi, et al.
Publicado: (2022)

piRNA-36741 regulates BMP2-mediated osteoblast differentiation via METTL3 controlled m6A modification
por: Liu, Jianmin, et al.
Publicado: (2021)

METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2021)

MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2
por: Hu, Shaojun, et al.
Publicado: (2022)

METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma
por: Shi, Kesong, et al.
Publicado: (2023)

METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3
por: Yi, Jianmei, et al.
Publicado: (2023)

Mettl3-dependent m(6)A modification attenuates the brain stress response in Drosophila
por: Perlegos, Alexandra E., et al.
Publicado: (2022)

METTL3-mediated m(6)A modification stabilizes TERRA and maintains telomere stability
por: Chen, Liping, et al.
Publicado: (2022)

DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer
por: Zhu, Miaohua, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
por: Li, Zhenjin, et al.
Publicado: (2023)

A cryptic pocket in METTL3-METTL14 regulates m(6)A conversion and sensing
por: Qi, Shan, et al.
Publicado: (2023)

METTL14 Regulates Intestine Cellular Senescence through m(6)A Modification of Lamin B Receptor
por: Zhang, Zizhen, et al.
Publicado: (2022)

METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma
por: Wu, Yingtong, et al.
Publicado: (2021)

METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho
por: Li, Manna, et al.
Publicado: (2021)

NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc
por: Meng, Sibo, et al.
Publicado: (2023)

Deciphering the map of METTL14‐mediated lncRNA m6A modification at the transcriptome‐wide level in breast cancer
por: Yi, Dandan, et al.
Publicado: (2022)

[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
por: Zhang, Yongxi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_39deg1gjt0hvrle7s3milhqcgs